Rigel Pharmaceuticals, Inc Security Rating

Unclaimed

Industry Pharmaceutical
Footprint 27 IPs
Followers Monitored by 18 companies
Year founded 1996
Employees 163

Rigel Pharmaceuticals, Inc. is a biotechnology company dedicated to discovering, developing and providing novel, small molecule drugs that significantly improve the lives of patients with immune and hematological disorders, cancer and rare diseases. Rigel's pioneering research focuses on signaling pathways that are critical to disease mechanisms. Its clinical programs include clinical trials of fostamatinib, an oral spleen tyrosine kinase (SYK) inhibitor, in a number of indications. The Company has submitted an NDA to the FDA for fostamatinib in patients with chronic or persistent ITP. The investigation of fostamatinib also includes Phase 2 clinical trials for autoimmune hemolytic anemia and IgA nephropathy.

98/ 100

Start Free Trial

SecurityScorecard calculates cybersecurity scores based on 10 factors that reflect different cybersecurity practices and risks.

Learn more about our scoring methodology

What do our scores mean?

We learned from over 12 million cybersecurity ratings that companies with an F are 13.8 times more likely to be impacted by a breach versus those with an A.

Visit Our Scorecard

Business prospects want to know that you're maintaining a strong cybersecurity program. Show it off with a free SecurityScorecard badge.

How to use badges

SpaceX’s ninth test flight of Starship launches into space, ends in a spin

techcrunch.com

Don't click on that Facebook ad for a text-to-AI-video tool

go.theregister.com

Anthropic debuts Claude conversational voice mode on mobile that searches your Google Docs, Drive, Calendar

venturebeat.com

Security leaders lose visibility as consultants deploy shadow AI copilots to stay employed

venturebeat.com

Adidas Falls Victim to Third-Party Data Breach

darkreading.com

Zscaler to Acquire MDR Specialist Red Canary

securityweek.com

Explore Top Companies

Footprint

issue

factor

grade

SecurityScorecard collects billions of signals each week, helping organizations see risks, get more actionable information, and respond faster to keep up with threat actors. Security teams are able to react quickly to digital criminals, respond to Zero-Day incidents faster, and reduce the risk exposure timeline.

Learn More About Security Signals

These are some of the factors we use to calculate the overall score:

Network Security

Discover open access points, insecure or misconfigured SSL certificates, or database vulnerabilities.

Patching Cadence

Understand how diligently a company is patching its operating systems, services, applications, software, and hardware in a timely manner.

IP Reputation

See the quantity and duration of malware infections, along with other factors influence the overall assessment of an organization’s IP Reputation.

Endpoint Security

Understand the effectiveness of protections in place for laptops, desktops, mobile devices, and all employee devices that access that company’s network.

How is your Scorecard calculated?

Take a look at the 10 factor categories at the core of SecurityScorecard’s cybersecurity rating methodology.

Embed security into your company DNA

Cyber risk ratings influence business activity from the loading dock to the board room. Learn all how to incorporate security ratings insights into workflows throughout your organization

Scorecards deliver real value

How do you quantify cyber risk management? Threat prevention may be hard to compute, but Forrester Consulting has done the work or you. Spoiler alert: SecurityScorecard customers realize investment payback in under a quarter.

11,000,000+ companies rated

Get your free Security Ratings report to see your custom score

Get Free Report

Rigel Pharmaceuticals, Inc Security Rating

SecurityScorecard Badge

Latest news